1. Home
  2. STHO vs OVID Comparison

STHO vs OVID Comparison

Compare STHO & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STHO

Star Holdings Shares of Beneficial Interest

N/A

Current Price

$8.05

Market Cap

104.6M

Sector

Real Estate

ML Signal

N/A

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

N/A

Current Price

$2.00

Market Cap

117.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STHO
OVID
Founded
2022
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.6M
117.5M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
STHO
OVID
Price
$8.05
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$3.40
AVG Volume (30 Days)
29.9K
1.5M
Earning Date
05-20-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
24.73
3.90
EPS
N/A
N/A
Revenue
$110,143,000.00
$566,000.00
Revenue This Year
N/A
$1,077.56
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$0.24
52 Week High
$9.24
$2.38

Technical Indicators

Market Signals
Indicator
STHO
OVID
Relative Strength Index (RSI) 40.42 67.31
Support Level $7.72 $1.43
Resistance Level $8.09 $2.01
Average True Range (ATR) 0.24 0.15
MACD -0.09 0.05
Stochastic Oscillator 9.09 60.11

Price Performance

Historical Comparison
STHO
OVID

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: